Business
Results for the year ended 31 December 2017
Results for the year ended 31 December 2017.

About this update from Croda International Plc
[{"type":"text","content":"\n \nRNS Number : 9822F Croda International PLC 27 February 2018 \n\n27 February 2018 \n \nResults for the year ended 31 December 2017\n \nRecord profit and strong sales growth\nCroda International Plc (\"Croda\" or the \"Group\"), the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally, today announces its full year results for the year ended 31 December 2017.\n\n\n\n\n \n\n\n2017 reported currency\n\n\nConstant\ncurrency\nchange\n\n\n2016\n\n\n\n\n \n \n\n\n \n£m\n\n\nYear on year change\n\n\n \n£m\n\n\n\n\nSales\n\n\n1,373.1\n\n\n+10.4%\n\n\n+4.6%\n\n\n1,243.6\n\n\n\n\nAdjusted operating profit\n\n\n332.2\n\n\n+11.4%\n\n\n+6.9%\n\n\n298.2\n\n\n\n\nAdjusted profit before tax\n\n\n320.3\n\n\n+11.1%\n\n\n+6.5%\n\n\n288.3\n\n\n\n\nAdjusted basic earnings per share\n\n\n179.0p\n\n\n+14.9%\n\n\n+10.5%\n\n\n155.8p\n\n\n\n\nNet debt\n\n\n381.5\n\n\n+4.8%\n\n\n \n\n\n364.1\n\n\n\n\nLeverage (net debt/EBITDA)\n\n\n1.0x\n\n\n(0.1)x\n\n\n \n\n\n1.1x\n\n\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n\nIFRS profit before tax\n\n\n314.1\n\n\n+13.9%\n\n\n \n\n\n275.7\n\n\n\n\nIFRS basic earnings per share\n\n\n180.8p\n\n\n+22.0%\n\n\n \n\n\n148.2p\n\n\n\n\nOrdinary dividend per share (declared)\n\n\n81.0p\n\n\n+9.5%\n\n\n \n\n\n74.0p\n\n\n\n\n \nGroup highlights (reported currency):\n· Record profit - excellent growth reflecting continued progress across all core sectors. Adjusted profit before tax up 11.1% at £320.3m and IFRS profit before tax up 13.9% at £314.1m\n· Strong sales growth - up 10.4%, driven by ongoing focus on premium, faster growth niches in Personal Care, Life Sciences and Performance Technologies, together with positive currency translation\n· Continued innovation - fifth consecutive year of New & Protected Products (NPP) sales growth\n· Improved margin - return on sales up 20 basis points to 24.2%, with ROIC stable at 19.2%.\nHighlights (constant currency): \n· Group: robust top and bottom line organic growth - adjusted operating profit up 6.9% on sales 4.6% higher, the strongest organic sales ...